BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

873 related articles for article (PubMed ID: 30825232)

  • 1. Expression profiling of long noncoding RNAs associated with vasculogenic mimicry in osteosarcoma.
    Ren K; Ni Y; Li X; Wang C; Chang Q; Li Y; Gao Z; Wu S; Shi X; Song J; Yao N; Zhou J
    J Cell Biochem; 2019 Aug; 120(8):12473-12488. PubMed ID: 30825232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Migration-inducing gene-7 independently predicts poor prognosis of human osteosarcoma and is associated with vasculogenic mimicry.
    Ren K; Zhang J; Gu X; Wu S; Shi X; Ni Y; Chen Y; Lu J; Gao Z; Wang C; Yao N
    Exp Cell Res; 2018 Aug; 369(1):80-89. PubMed ID: 29750896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA n339260 promotes vasculogenic mimicry and cancer stem cell development in hepatocellular carcinoma.
    Zhao X; Sun B; Liu T; Shao B; Sun R; Zhu D; Zhang Y; Gu Q; Dong X; Liu F; Zhao N; Zhang D; Li Y; Meng J; Gong W; Zheng Y; Zheng X
    Cancer Sci; 2018 Oct; 109(10):3197-3208. PubMed ID: 30022558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of potential crucial genes associated with vasculogenic mimicry in human osteosarcoma based on gene expression profile.
    Yao N; Ren K; Gu XJ; Wu SJ; Shi X; Chang Q; Li YG; Gao ZX; Jin QM; Zhang J; Wang C; Zhou J
    Neoplasma; 2020 Mar; 67(2):286-295. PubMed ID: 31884799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. lncRNA nuclear-enriched abundant transcript 1 promotes cell proliferation and invasion by targeting miR-186-5p/HIF-1α in osteosarcoma.
    Tan H; Zhao L
    J Cell Biochem; 2019 Apr; 120(4):6502-6514. PubMed ID: 30485482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of long non-coding RNA NNT-AS1 promotes osteosarcoma progression by inhibiting the tumor suppressive miR-320a.
    Li C; Zhang S; Qiu T; Wang Y; Ricketts DM; Qi C
    Cancer Biol Ther; 2019; 20(4):413-422. PubMed ID: 30489194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA tumor suppressor candidate 7 functions as a tumor suppressor and inhibits proliferation in osteosarcoma.
    Cong M; Li J; Jing R; Li Z
    Tumour Biol; 2016 Jul; 37(7):9441-50. PubMed ID: 26781978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive analysis of the long noncoding RNA expression profile and construction of the lncRNA-mRNA co-expression network in colorectal cancer.
    Zhang Q; Ding Z; Wan L; Tong W; Mao J; Li L; Hu J; Yang M; Liu B; Qian X
    Cancer Biol Ther; 2020; 21(2):157-169. PubMed ID: 31619123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA AFAP1-AS1 promotes tumorigenesis and epithelial-mesenchymal transition of osteosarcoma through RhoC/ROCK1/p38MAPK/Twist1 signaling pathway.
    Shi D; Wu F; Mu S; Hu B; Zhong B; Gao F; Qing X; Liu J; Zhang Z; Shao Z
    J Exp Clin Cancer Res; 2019 Aug; 38(1):375. PubMed ID: 31443665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA BCAR4 promotes osteosarcoma progression through activating GLI2-dependent gene transcription.
    Chen F; Mo J; Zhang L
    Tumour Biol; 2016 Oct; 37(10):13403-13412. PubMed ID: 27460090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA expression profiles of the doxorubicin-resistant human osteosarcoma cell line MG63/DXR and its parental cell line MG63 as ascertained by microarray analysis.
    Zhu KP; Zhang CL; Shen GQ; Zhu ZS
    Int J Clin Exp Pathol; 2015; 8(8):8754-73. PubMed ID: 26464619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant expression of long noncoding RNAs in early diabetic retinopathy.
    Yan B; Tao ZF; Li XM; Zhang H; Yao J; Jiang Q
    Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):941-51. PubMed ID: 24436191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA FTX inhibition restrains osteosarcoma proliferation and migration via modulating miR-320a/TXNRD1.
    Huang S; Zhu X; Ke Y; Xiao D; Liang C; Chen J; Chang Y
    Cancer Biol Ther; 2020 Apr; 21(4):379-387. PubMed ID: 31920141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptome analysis identified a novel 3-LncRNA regulatory network of transthyretin attenuating glucose induced hRECs dysfunction in diabetic retinopathy.
    Shao J; Zhang Y; Fan G; Xin Y; Yao Y
    BMC Med Genomics; 2019 Oct; 12(1):134. PubMed ID: 31615521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
    Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z
    Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long intergenic non-protein coding RNA 511 promotes the progression of osteosarcoma cells through sponging microRNA 618 to upregulate the expression of maelstrom.
    Guo W; Yu Q; Zhang M; Li F; Liu Y; Jiang W; Jiang H; Li H
    Aging (Albany NY); 2019 Aug; 11(15):5351-5367. PubMed ID: 31386627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TFAP2C-mediated LINC00922 signaling underpins doxorubicin-resistant osteosarcoma.
    Gu Z; Zhou Y; Cao C; Wang X; Wu L; Ye Z
    Biomed Pharmacother; 2020 Sep; 129():110363. PubMed ID: 32563982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive analysis of lncRNA-mRNA co-expression networks in HPV-driven cervical cancer reveals the pivotal function of LINC00511-PGK1 in tumorigenesis.
    Xin X; Jia-Yin Y; Jun-Yang H; Rui W; Xiong-Ri K; Long-Rui D; Liu J; Jue-Yu Z
    Comput Biol Med; 2023 Jun; 159():106943. PubMed ID: 37099974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathway analysis of a genome‑wide association study on a long non‑coding RNA expression profile in oral squamous cell carcinoma.
    Qiu YL; Liu YH; Ban JD; Wang WJ; Han M; Kong P; Li BH
    Oncol Rep; 2019 Feb; 41(2):895-907. PubMed ID: 30431131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA CTA sensitizes osteosarcoma cells to doxorubicin through inhibition of autophagy.
    Wang Z; Liu Z; Wu S
    Oncotarget; 2017 May; 8(19):31465-31477. PubMed ID: 28415557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.